Arcutis Biotherapeutics (ARQT) Total Debt (2021 - 2026)
Arcutis Biotherapeutics (ARQT) posted quarterly Total Debt of $117.4 million for Q1 2026, up 9.06% year-over-year from $107.6 million in Q1 2025, and up 6.74% quarter-over-quarter from $110.0 million in Q4 2025.
Arcutis Biotherapeutics (ARQT) Total Debt (2021 - 2026) Analysis & Trends
Arcutis Biotherapeutics' Total Debt history runs 6 years deep, the most recent figure standing at $117.4 million for Q1 2026.
- In Q1 2026, Total Debt rose 9.06% year-over-year to $117.4 million; the TTM figure through Mar 2026 stood at $117.4 million (up 9.06% YoY), while the FY2025 annual figure was $110.0 million, up 2.57% from the prior year.
- Total Debt for Q1 2026 stood at $117.4 million, up from $110.0 million in the prior quarter.
- The five-year high for Total Debt was $204.6 million in Q3 2024, with the low at $72.7 million in Q1 2022.
- The 5-year median for Total Debt is $196.8 million (2022), against an average of $153.6 million.
- The sharpest annual moves came in 2022 and 2025: Total Debt soared 173.35% in 2022, then tumbled 46.98% in 2025.
- Arcutis Biotherapeutics' Total Debt stood at $197.8 million in 2022, then increased by 2.04% to $201.8 million in 2023, then sank by 46.88% to $107.2 million in 2024, then advanced by 2.57% to $110.0 million in 2025, then climbed by 6.74% to $117.4 million in 2026.
- Business Quant data shows ARQT's Total Debt at $117.4 million in Q1 2026, $110.0 million in Q4 2025, and $108.5 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Debt (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 1.99 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | - |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 1.07 Bn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | - |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 9.34 Bn |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | - |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | 546.77 Mn |
| 10 | Arcutis Biotherapeutics | 3.29 Bn | 3.05 Bn | 118.92 Mn | 115.85 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 115.85 Mn |
| Mar 31, 2026 | 117.37 Mn |
| Dec 31, 2025 | 109.96 Mn |
| Sep 30, 2025 | 108.50 Mn |
| Jun 30, 2025 | 108.05 Mn |
| Mar 31, 2025 | 107.62 Mn |
| Dec 31, 2024 | 107.20 Mn |
| Sep 30, 2024 | 204.61 Mn |
| Jun 30, 2024 | 203.81 Mn |
| Mar 31, 2024 | 202.80 Mn |
| Dec 31, 2023 | 201.80 Mn |
| Sep 30, 2023 | 200.78 Mn |
| Jun 30, 2023 | 199.77 Mn |
| Mar 31, 2023 | 198.76 Mn |
| Dec 31, 2022 | 197.77 Mn |
| Sep 30, 2022 | 196.75 Mn |
| Jun 30, 2022 | 73.14 Mn |
| Mar 31, 2022 | 72.74 Mn |
| Dec 31, 2021 | 72.35 Mn |